Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.760
+0.170 (3.70%)
At close: Aug 19, 2026, 4:00 PM EDT
4.810
+0.050 (1.05%)
After-hours: Aug 19, 2026, 7:30 PM EDT
Nephros Revenue
Nephros had revenue of $6.02M in the quarter ending June 30, 2026, with 36.16% growth. This brings the company's revenue in the last twelve months to $20.72M, up 24.20% year-over-year. In the year 2025, Nephros had annual revenue of $18.79M with 32.67% growth.
Revenue (ttm)
$20.72M
Revenue Growth
+24.20%
P/S Ratio
2.49
Revenue / Employee
$575,611
Employees
36
Market Cap
51.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.79M | 4.63M | 32.67% |
| Dec 31, 2024 | 14.16M | -76.00K | -0.53% |
| Dec 31, 2023 | 14.24M | 4.26M | 42.74% |
| Dec 31, 2022 | 9.98M | -242.00K | -2.37% |
| Dec 31, 2021 | 10.22M | 1.66M | 19.34% |
| Dec 31, 2020 | 8.56M | -1.77M | -17.16% |
| Dec 31, 2019 | 10.33M | 4.65M | 81.71% |
| Dec 31, 2018 | 5.69M | 1.88M | 49.30% |
| Dec 31, 2017 | 3.81M | 1.49M | 64.18% |
| Dec 31, 2016 | 2.32M | 376.00K | 19.34% |
| Dec 31, 2015 | 1.94M | 196.00K | 11.21% |
| Dec 31, 2014 | 1.75M | 8.00K | 0.46% |
| Dec 31, 2013 | 1.74M | -67.00K | -3.71% |
| Dec 31, 2012 | 1.81M | -407.00K | -18.38% |
| Dec 31, 2011 | 2.21M | -724.00K | -24.64% |
| Dec 31, 2010 | 2.94M | 277.00K | 10.41% |
| Dec 31, 2009 | 2.66M | 1.19M | 80.65% |
| Dec 31, 2008 | 1.47M | 277.00K | 23.16% |
| Dec 31, 2007 | 1.20M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 87.81M |
| KORU Medical Systems | 45.11M |
| Retractable Technologies | 33.90M |
| Bionano Genomics | 30.18M |
| Stereotaxis | 30.07M |
| Precision Optics Corporation | 28.94M |
| Nyxoah | 24.75M |
| Jin Medical International | 19.73M |
NEPH News
- 13 days ago - Nephros reports Q2 EPS 11c, consensus 0c - TheFly
- 13 days ago - Nephros Earnings Call Transcript: Q2 2026 - Transcripts
- 13 days ago - Nephros Earnings release: Q2 2026 - Filings
- 13 days ago - Nephros Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Nephros initiated with a Market Perform at Northland - TheFly
- 4 weeks ago - Nephros Transcript: Investor update - Transcripts
- 5 weeks ago - Nephros Slides: Corporate presentation - Filings
- 6 weeks ago - Nephros Announces Inclusion in the Russell Microcap® Index - GlobeNewsWire